Terens Natalie, Vecchi Simona, Bargagli Anna Maria, Agabiti Nera, Mitrova Zuzana, Amato Laura, Davoli Marina
Trenton Health Team, Trenton, New Jersey, USA.
Department of Epidemiology, Lazio Region- ASL Rome1, Rome, Italy.
BMC Endocr Disord. 2018 May 29;18(1):31. doi: 10.1186/s12902-018-0260-4.
There is evidence that disparities exist in diabetes prevalence, access to diabetes care, diabetes-related complications, and the quality of diabetes care. A wide range of interventions has been implemented and evaluated to improve diabetes care. We aimed to review trials of quality improvement (QI) interventions aimed to reduce health inequities among people with diabetes in primary care and to explore the extent to which experimental studies addressed and reported equity issues.
Pubmed, EMBASE, CINAHL, and the Cochrane Library were searched to identify randomized controlled studies published between January 2005 and May 2016. We adopted the PROGRESS Plus framework, as a tool to explore differential effects of QI interventions across sociodemographic and economic factors.
From 1903 references fifty-eight randomized trials met the inclusion criteria (with 17.786 participants), mostly carried out in USA. The methodological quality was good for all studies. Almost all studies reported the age, gender/sex and race distribution of study participants. The majority of trials additionally used at least one further PROGRESS-Plus factor at baseline, with education being the most commonly used, followed by income (55%). Large variation was observed between these studies for type of interventions, target populations, and outcomes evaluated. Few studies examined differential intervention effects by PROGRESS-plus factors. Existing evidence suggests that some QI intervention delivered in primary care can improve diabetes-related health outcomes in social disadvantaged population subgroups such as ethnic minorities. However, we found very few studies comparing health outcomes between population subgroups and reporting differential effect estimates of QI interventions.
This review provides evidence that QI interventions for people with diabetes is feasible to implement and highly acceptable. However, more research is needed to understand their effective components as well as the adoption of an equity-oriented approach in conducting primary studies. Moreover, a wider variety of socio-economic characteristics such as social capital, place of residence, occupation, education, and religion should be addressed.
有证据表明,在糖尿病患病率、获得糖尿病护理的机会、糖尿病相关并发症以及糖尿病护理质量方面存在差异。为改善糖尿病护理,已实施并评估了广泛的干预措施。我们旨在回顾旨在减少初级保健中糖尿病患者健康不平等的质量改进(QI)干预试验,并探讨实验研究解决和报告公平问题的程度。
检索了PubMed、EMBASE、CINAHL和Cochrane图书馆,以识别2005年1月至2016年5月期间发表的随机对照研究。我们采用PROGRESS Plus框架,作为探索QI干预在社会人口和经济因素方面差异效应的工具。
从1903篇参考文献中,58项随机试验符合纳入标准(有17786名参与者),大部分在美国进行。所有研究的方法学质量都很好。几乎所有研究都报告了研究参与者的年龄、性别和种族分布。大多数试验在基线时还额外使用了至少一个其他的PROGRESS-Plus因素,其中教育是最常用的,其次是收入(55%)。这些研究在干预类型、目标人群和评估结果方面存在很大差异。很少有研究按PROGRESS-plus因素检查差异干预效果。现有证据表明,在初级保健中实施的一些QI干预可以改善社会弱势群体(如少数民族)亚组中与糖尿病相关的健康结果。然而,我们发现很少有研究比较人群亚组之间的健康结果并报告QI干预的差异效应估计。
本综述提供的证据表明,针对糖尿病患者的QI干预实施可行且高度可接受。然而,需要更多的研究来了解其有效成分,以及在进行初级研究时采用以公平为导向的方法。此外,应该考虑更广泛的社会经济特征,如社会资本、居住地、职业、教育和宗教。